By Bhanvi Satija and Puyaan Singh (Reuters) -Johnson & Johnson said on Monday it will buy neurological drugmaker ...

Robeauté’s microrobots can enter the brain to diagnose, treat and monitor neurological conditions in a way that was ...

Johnson & Johnson said on Monday it would buy drugmaker Intra-Cellular Therapies for about $14.6 billion, boosting its ...

By establishing coding and separate payment for certain digital mental health devices, this group from CMS and the FDA hopes ...

Despite the advances in antibiotic treatments, ear infections can still lead to severe neurological complications such as ...

The system received a $1.5 million donation from the Ben Taub and Henry J.N. Taub Foundation to support research and ...

Groundbreaking research reveals potential link between cytomegalovirus (CMV) and Alzheimer's disease, offering new insights ...

On Tuesday, January 7, the FDA announced it would now be requiring GSK and Pfizer’s RSV vaccines to hold warnings of a risk ...

Theranexus has announced the publication of its letter to shareholders, highlighting its ongoing efforts in developing treatments for rare neurological disorders. This communication demonstrates ...

A treatment that could potentially slow the progression of amyotrophic lateral sclerosis (ALS) is being studied at the ...

Analysts expect the treatment to bring in more than $1 billion ... Shagun Singh said the deal fit strategically into J&J's neurological drugs division, an important area for the company.